---
title: "RGLS.US (RGLS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RGLS.US/news.md"
symbol: "RGLS.US"
name: "RGLS.US"
parent: "https://longbridge.com/en/quote/RGLS.US.md"
datetime: "2026-03-13T21:02:47.534Z"
locales:
  - [en](https://longbridge.com/en/quote/RGLS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RGLS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RGLS.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/RGLS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/RGLS.US/news.md)


# RGLS.US (RGLS.US) — Related News

### [Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion](https://longbridge.com/en/news/246521182.md)
*2025-06-28T17:04:47.000Z*
> Novartis AG has completed its acquisition of Regulus Therapeutics for $1.7 billion, confirming the deal on June 23. Foll

### [Novartis' tender offer to acquire all shares of Regulus for $7.00 in cash per share and one contingent value right has expired.](https://longbridge.com/en/news/246013640.md)
*2025-06-25T05:17:49.000Z*
> Novartis' tender offer to acquire all shares of Regulus Therapeutics Inc. for $7.00 in cash per share, along with one co

### [](https://longbridge.com/en/news/245626620.md)
*2025-06-23T05:27:09.000Z*
> Novartis: HSR Waiting Period For Regulus Acquisition Has Ended

### [Novartis announces expiration of HSR waiting period of Regulus Therapeutics tender offer](https://longbridge.com/en/news/245624794.md)
*2025-06-23T05:00:00.000Z*
> Novartis has announced the expiration of the HSR waiting period for its tender offer to acquire Regulus Therapeutics. Th

### [Regulus Therapeutics Inc. (NASDAQ:RGLS) Insider Preston Klassen Acquires 12,000 Shares](https://longbridge.com/en/news/243272469.md)
*2025-06-05T11:59:28.000Z*
> Regulus Therapeutics Inc. insider Preston Klassen acquired 12,000 shares at $7.99 each, totaling $95,880, increasing his

### [Regulus Therapeutics Inc. (NASDAQ:RGLS) Short Interest Update](https://longbridge.com/en/news/242819462.md)
*2025-06-02T18:56:11.000Z*
> Regulus Therapeutics Inc. (NASDAQ:RGLS) experienced a significant decrease in short interest, dropping 29.5% to 1,910,00

### [Novartis to acquire Regulus Therapeutics by offering $7 in cash per share plus one contingent value right per share.](https://longbridge.com/en/news/242014876.md)
*2025-05-27T12:17:10.000Z*
> Novartis has announced a tender offer to acquire Regulus Therapeutics for $7.00 in cash per share, plus one contingent v